Multiple Sclerosis (MS) Drug Market

MedPage Today  3 hrs ago  Comment 
(MedPage Today) -- What is vitamin D's role in multiple sclerosis? Four experts told us that the epidemiological evidence for an influence is indisputable, but whether supplements make a difference is still up in the air.
MedPage Today  Apr 16  Comment 
(MedPage Today) -- What is the best way to measure disability progression in multiple sclerosis patients? Two specialists took on the question and outlined a variety of available tools including standardized scales, MRI scans, and clinical judgment.
MedPage Today  Apr 15  Comment 
(MedPage Today) -- What are the most under-recognized and undertreated aspects of multiple sclerosis? Three prominent MS specialists shared their thoughts, spanning sleep disruption, bladder problems, and cognitive impairment.
MedPage Today  Apr 14  Comment 
(MedPage Today) -- What are the most promising therapies for progressive multiple sclerosis? We asked three well known researchers and clinicians, who noted that drugs currently approved for relapsing-remitting MS as well as a host of new...
SeekingAlpha  Apr 10  Comment 
ByRichard Richter: Pathogenic infections are understandable. A foreign organism invades your body and you get sick. The immune system eventually takes care of it, sometimes with the help of other drugs. Autoimmune disorders, on the other hand, are...
Reuters  Apr 7  Comment 
Specialty pharmaceuticals company Mallinckrodt Plc will buy drugmaker Questcor Pharmaceuticals Inc for about $5.6 billion to gain access to its multiple sclerosis drug, Acthar Gel, which...
FierceBiotech  Apr 7  Comment 
Sanofi is walking away from any plans to appeal the FDA's emphatic rejection of the multiple sclerosis drug Lemtrada, at least for now. But rather than launching the added trial that the FDA demanded ahead of any possible approval, the company...
MedPage Today  Mar 20  Comment 
(MedPage Today) -- Two clinical trials are now underway that offer the first tests of an intriguing but still not widely accepted theory of multiple sclerosis -- that its trigger lies within a part of the human genome that medical research has...
SeekingAlpha  Mar 20  Comment 
By Peter Geschek: Multiple sclerosis In 2013 the size of the global MS (multiple sclerosis) market was about $15 billion and the market is growing at a rate of 11 percent annually. Biogen Idec' (BIIB) share of that market was about the third...


Very nice site!

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki